Illumina (ILMN) EBITDA Margin (2009 - 2026)
Illumina (ILMN) posted quarterly EBITDA Margin of 21.14% for Q2 2026, up 93.0% year-over-year from 10.95% in Q2 2025, and up 10.35% on a QoQ basis from 19.16% in Q1 2026.
Illumina (ILMN) EBITDA Margin (2009 - 2026) Analysis & Trends
Illumina has reported EBITDA Margin for 18 years, with the latest figure at 21.14% in Q2 2026.
- EBITDA Margin for Q2 2026 came in at 21.14%, up 93.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 19.63% (down 1057.0% YoY), and the FY2025 annual result was 18.58%, up 3763.0% from the prior year.
- EBITDA Margin grew to 21.14% in Q2 2026, from 19.16% in the prior quarter.
- Over five years, EBITDA Margin peaked at 68.61% in Q3 2024 and troughed at 327.98% in Q4 2022.
- A 5-year average of 40.89% and a median of 4.58% in 2022 frame the typical range for EBITDA Margin.
- The widest annual swing landed in 2022, when EBITDA Margin tumbled 27879 bps; it then jumped 30479 bps in 2023.
- A 5-year view of EBITDA Margin shows it stood at 327.98% in 2022, then jumped by 96 bps to 14.62% in 2023, then soared by 208 bps to 15.85% in 2024, then climbed by 9 bps to 17.34% in 2025, then increased by 22 bps to 21.14% in 2026.
- Per Business Quant data, the three most recent EBITDA Margin figures were 21.14% in Q2 2026, 19.16% in Q1 2026, and 17.34% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.99% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.98% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 21.74% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 11.58% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -13.42% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 21.14% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 31.97% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.08% |
| 10 | Labcorp Holdings | 25.87 Bn | 24.89 Bn | 1.01 Bn | 10.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 21.14% |
| Mar 29, 2026 | 19.16% |
| Dec 28, 2025 | 17.34% |
| Sep 28, 2025 | 20.94% |
| Jun 29, 2025 | 20.21% |
| Mar 30, 2025 | 15.75% |
| Dec 29, 2024 | 15.85% |
| Sep 29, 2024 | 68.61% |
| Jun 30, 2024 | -147.21% |
| Mar 31, 2024 | -10.32% |
| Dec 31, 2023 | -14.62% |
| Oct 1, 2023 | -67.38% |
| Jul 2, 2023 | -7.48% |
| Apr 2, 2023 | -5.89% |
| Jan 1, 2023 | -319.41% |
| Oct 2, 2022 | -327.98% |
| Jul 3, 2022 | -49.83% |
| Apr 3, 2022 | 15.04% |
| Oct 3, 2021 | -49.19% |
| Jul 4, 2021 | 16.61% |